By Prudence Ujah, Abuja
In a bid to address the adverse effect of drug reactions in the country, key stakeholders have called for proper implementation of the Pharmacology Vigilance Africa (PAVIA) Project in Nigeria.
The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC) Professor Christianah Adeyeye who made the call on Monday in Abuja at the Country Specific meeting on Pharmaco Vigilance Africa (PAVIA) stressed that after the meeting, a baseline assessment of Pharmaco Vigilance (PV) activities in Nigeria will be conducted by PV Experts.
Adeyeye who was represented by the special Adviser to NAFDAC DG on Operations Gbenga Fajemirokun said the objectives of PAVIA is to improve efficiency and effectiveness of National Surveillance of Adverse Drug Reaction and implementation of tools and technologies for their detection, reporting, analysis and dissemination.
The Chief Executive Officer of the Institute of Human Virology Nigeria (IHVN) Dr Patric Dakum, called for a
structured implementation of pharmaco vigilance in Nigeria in other to address the issues of adverse drug reactions in Nigeria.
Dakum said ” it is crucial to institute pharmaco vigilance in African countries and encourage patients to talk about the side effects they experience as reporting of adverse drugs reactions is very low in the Nigeria. Reporting of adverse drugs reactions is less than 10% in Nigeria, but we worked with some institutions and they witnessed an increase to 60%. Therefore it is important to put the reporting mechanism in place in all institutions”.
The IHVN CEO added that for Tuberculosis (TB), “the monitoring of adverse drug reactions is key as we will ensure that all patients on TB medications are closely monitored for proper reporting of any adverse drugs reactions especially with Multi drug resistant Tuberculosis.”
The Chairman House Committee on Health Care Services Chike Okafor said there is a need for effective implementation of PAVIA project in Nigeria as it will help address the adverse side effects of medicines which is majorly under reported.
Okafor said that “inadequate coordination, lack of regulatory structures, limited experience in monitoring has contributed to the low reportage of Adverse drug reaction and its negative impact hence the need for increase in monitoring.
According to the lawmaker, PRAVIA project will help address the loopholes in the use of drugs, while he pledged that the house of Representatives is willing to ensure that the Pavia project is a success while he stressed that it is improper to play politics with the health of Nigerians.
The Minister of Health Professor Isaac Adewole who was represented by Pharmacist Lawal reteriated the need for improved efforts in monitoring drug reactions especially in the management of Tuberculosis in Nigeria.
The Nigeria Country Specific meeting on Pharmaco vigilance was organised by NAFDAC in collaboration with IHVN, University of Benin, National Tuberculosis and Leprosy Control Program and KNVC Tuberculosis foundation Nigeria to sensitize and solicit support of all relevant stakeholders towards the effective implementation of Pharmaco Vigilance Africa project in Nigeria.